Fjarde AP Fonden Fourth Swedish National Pension Fund Reduces Holdings in The Cooper Companies, Inc. $COO

Key Points

• Fjarde AP Fonden Fourth Swedish National Pension Fund reduced its stake in The Cooper Companies by 11.5% to 33,720 shares, valued at approximately $2,844,000.
• Multiple institutional investors have made changes to their stakes in COO, with Mirae Asset Global Investments increasing its stake by 15.1%, now owning 26,189 shares worth $2,194,000.
• Analyst ratings on The Cooper Companies are mixed, with three analysts rating it a hold, nine a buy, and a consensus target price of $96.73, indicating a current average rating of "Moderate Buy."

Fjarde AP Fonden Fourth Swedish National Pension Fund decreased its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 11.5% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 33,720 shares of the medical device company's stock after selling 4,400 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund's holdings in Cooper Companies were worth $2,844,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Zions Bancorporation National Association UT bought a new position in Cooper Companies in the first quarter worth about $33,000. City Holding Co. purchased a new position in shares of Cooper Companies during the 1st quarter worth approximately $34,000. GKV Capital Management Co. Inc. bought a new position in shares of Cooper Companies in the 1st quarter worth approximately $40,000. Larson Financial Group LLC lifted its stake in shares of Cooper Companies by 1,071.0% in the 1st quarter. Larson Financial Group LLC now owns 726 shares of the medical device company's stock valued at $61,000 after purchasing an additional 664 shares during the period. Finally, HM Payson & Co. boosted its position in shares of Cooper Companies by 147.4% during the first quarter. HM Payson & Co. now owns 893 shares of the medical device company's stock valued at $75,000 after purchasing an additional 532 shares in the last quarter. Institutional investors own 24.39% of the company's stock.

Analysts Set New Price Targets

A number of research firms have issued reports on COO. Needham & Company LLC upgraded Cooper Companies from a "hold" rating to a "buy" rating and set a $94.00 price objective for the company in a report on Tuesday, June 17th. Wells Fargo & Company decreased their price target on shares of Cooper Companies from $118.00 to $93.00 and set an "overweight" rating for the company in a research note on Friday, May 30th. BNP Paribas Exane raised shares of Cooper Companies from a "neutral" rating to an "outperform" rating and set a $92.00 price objective on the stock in a research note on Tuesday, July 22nd. UBS Group upgraded shares of Cooper Companies to a "buy" rating in a report on Tuesday, June 17th. Finally, Loop Capital set a $100.00 target price on shares of Cooper Companies in a report on Tuesday, June 17th. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, Cooper Companies currently has an average rating of "Moderate Buy" and an average price target of $96.73.

Cooper Companies Stock Down 0.6%

NASDAQ COO traded down $0.44 during mid-day trading on Thursday, reaching $73.06. The stock had a trading volume of 1,086,455 shares, compared to its average volume of 2,153,401. The stock has a market cap of $14.61 billion, a PE ratio of 35.45, a price-to-earnings-growth ratio of 1.81 and a beta of 1.00. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.10 and a quick ratio of 1.23. The Cooper Companies, Inc. has a 1 year low of $65.00 and a 1 year high of $112.38. The company has a fifty day moving average price of $72.02 and a 200 day moving average price of $78.62.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings data on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, topping the consensus estimate of $0.93 by $0.03. The company had revenue of $1 billion during the quarter, compared to the consensus estimate of $995.12 million. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%.Cooper Companies's revenue for the quarter was up 6.3% on a year-over-year basis. During the same period last year, the company earned $0.85 EPS. Cooper Companies has set its FY 2025 guidance at 4.050-4.110 EPS. On average, research analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.